<!DOCTYPE html>
<html lang="fa">
 <meta content="text/html;charset=utf-8" http-equiv="content-type"/>
 <head>
  <title>
   Acute rheumatic fever: Epidemiology and pathogenesis
  </title>
  <link href="d/css/1.css" rel="stylesheet"/>
 </head>
 <body>
  <!-- Start Main Menu Area -->
  <br/>
  <br/>
  <br/>
  <br/>
  <div class="container">
   <div class="row">
   </div>
  </div>
  <section class="teacher-area ptb-10">
   <div class="container">
   </div>
   <section class="course-details-area ptb-60">
    <div class="container">
     <div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
      <h1 style="text-align:center">
       Acute rheumatic fever: Epidemiology and pathogenesis
      </h1>
      <div class="utdArticleSection utdStyle" id="topicContent">
       <div id="topicTitle">
        Acute rheumatic fever: Epidemiology and pathogenesis
       </div>
       <div class="authorSectionElem">
        <div class="authorsElementsLeft">
         <dl id="topicContributors">
          <dt>
           <span>
           </span>
           Authors:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Andrew Steer, MBBS, PhD, FRACP
           </a>
          </dd>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Allan Gibofsky, MD, JD, FACP, FCLM
           </a>
          </dd>
          <dt>
           <span>
           </span>
           Section Editors:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Robert Sundel, MD
           </a>
          </dd>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Daniel J Sexton, MD
           </a>
          </dd>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Sheldon L Kaplan, MD
           </a>
          </dd>
          <dt>
           <span>
           </span>
           Deputy Editor:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Philip Seo, MD, MHS
           </a>
          </dd>
         </dl>
        </div>
        <div class="authorsElementsRight">
         <div id="literatureReviewDate">
          <div class="litReviewSingleLine">
           <bdi>
            <span class="emphasis">
             Literature review current through:
            </span>
            Jan 2024.
           </bdi>
          </div>
          <div class="litReviewSingleLine">
           <bdi>
            <span class="emphasis">
             This topic last updated:
            </span>
            Sep 28, 2023.
           </bdi>
          </div>
         </div>
        </div>
       </div>
       <div id="topicWhatsNewContainer">
       </div>
       <div id="topicText">
        <p class="headingAnchor" id="H1">
         <span class="h1">
          INTRODUCTION
         </span>
         <span class="headingEndMark">
          —
         </span>
         The potential complications of group A
         <em>
          Streptococcus
         </em>
         (GAS) pharyngeal infection include both suppurative (eg, peritonsillar abscess, otitis media, sinusitis) and inflammatory, nonsuppurative conditions. Acute rheumatic fever (ARF) is one of the nonsuppurative complications (others include scarlet fever and acute glomerulonephritis [AGN]). There is a latent period of two to three weeks following the initial pharyngitis before the first signs or symptoms of ARF appear [
         <a href="#rid1">
          1
         </a>
         ]. The disease presents with various manifestations that may include arthritis or arthralgia, carditis, chorea, subcutaneous nodules, and erythema marginatum.
        </p>
        <p>
         The epidemiology and pathogenesis of ARF are reviewed here. The clinical manifestations, diagnosis, treatment, and prevention of this disorder are discussed separately. (See
         <a class="medical medical_review" href="/z/d/html/3177.html" rel="external">
          "Acute rheumatic fever: Clinical manifestations and diagnosis"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/3175.html" rel="external">
          "Acute rheumatic fever: Treatment and prevention"
         </a>
         .)
        </p>
        <p>
         Other complications of streptococcal tonsillopharyngitis are also discussed separately. (See
         <a class="medical medical_review" href="/z/d/html/8046.html" rel="external">
          "Complications of streptococcal tonsillopharyngitis"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H2">
         <span class="h1">
          EPIDEMIOLOGY
         </span>
         <span class="headingEndMark">
          —
         </span>
         In low-resource areas of the world, severe disease caused by group A
         <em>
          Streptococcus
         </em>
         (GAS; eg, ARF, rheumatic heart disease, glomerulonephritis, and invasive infections) is estimated to affect over 33 million people, and rheumatic heart disease is the leading cause of cardiovascular death during the first five decades of life [
         <a href="#rid2">
          2
         </a>
         ]. ARF can occur at any age, although most cases occur in children 5 to 15 years of age [
         <a href="#rid3">
          3-5
         </a>
         ]. Worldwide, based upon conservative estimates, there are approximately 470,000 new cases of ARF and 320,000 deaths attributable to rheumatic heart disease each year [
         <a href="#rid6">
          6-9
         </a>
         ]. Most cases occur in low- and middle-income countries and among indigenous populations, with risk factors including overcrowding and limited access to health care [
         <a href="#rid10">
          10
         </a>
         ]. Regions with the highest rates are likely to have the least accurate data, with substantial underreporting.
        </p>
        <p>
         The mean incidence of ARF is 19 per 100,000 school-aged children worldwide [
         <a href="#rid11">
          11
         </a>
         ], but it is lower (≤2 cases per 100,000 school-aged children) in the United States and other high-resource countries, having declined since the middle of last century [
         <a href="#rid12">
          12-14
         </a>
         ]. In many low- and middle-income countries and in certain Indigenous populations, such as those in Australia and New Zealand, the incidence of ARF is substantially higher, with some of the highest rates reported in Indigenous Australians at 153 to 380 cases per 100,000 children aged 5 to 14 years [
         <a href="#rid4">
          4
         </a>
         ].
        </p>
        <p>
         The higher incidence in low-resource countries is primarily explained by environmental factors, especially household overcrowding, which favors increased transmission of GAS [
         <a href="#rid15">
          15
         </a>
         ], and in smaller part by routine use of antibiotics for acute pharyngitis. Overcrowding is also a strong risk factor for ARF in high-resource countries, including New Zealand, where household crowding was associated with a fourfold increased risk [
         <a href="#rid16">
          16
         </a>
         ]. From time to time, localized outbreaks of ARF occur [
         <a href="#rid17">
          17-22
         </a>
         ]. They may be associated with specific strains of GAS, though this alone cannot explain overall variations in the incidence of rheumatic fever [
         <a href="#rid23">
          23
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/6867.html" rel="external">
          "Evaluation of acute pharyngitis in adults"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/5971.html" rel="external">
          "Group A streptococcal tonsillopharyngitis in children and adolescents: Clinical features and diagnosis"
         </a>
         .)
        </p>
        <p>
         Up to 3 percent of episodes of untreated acute streptococcal pharyngitis were followed by ARF during epidemics in the mid-1900s. In contrast, the incidence of ARF is substantially less (approximately 1 percent) during times of endemic infections [
         <a href="#rid24">
          24
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H4">
         <span class="h1">
          PATHOGENESIS
         </span>
        </p>
        <p class="headingAnchor" id="H853693162">
         <span class="h2">
          Overview
         </span>
         <span class="headingEndMark">
          —
         </span>
         The pathogenic mechanisms that lead to the development of ARF remain incompletely understood. Studies of the pathogenesis of ARF have been constrained by the lack of a suitable animal model, although a Lewis rat model of valvulitis and chorea has been used for some time [
         <a href="#rid25">
          25,26
         </a>
         ]. Streptococcal pharyngeal infection clearly plays a roll, although the antecedent pharyngitis is often mild and not recollected. The number of streptococcal infections (both pharyngeal and skin infection) may also be important, with repeated infections possibly priming the immune system. Genetic susceptibility may be present. Within this framework, tissue injury is thought to be caused by an autoimmune process generated by cross-reactive antibodies and T cells between group A
         <em>
          Streptococcus
         </em>
         (GAS) antigens and human tissue.
        </p>
        <p class="headingAnchor" id="H1159580917">
         <span class="h2">
          Immune response to infection
         </span>
         <span class="headingEndMark">
          —
         </span>
         Following GAS pharyngeal infection, activation of the innate immune system leads to GAS antigen presentation to T cells  (
         <a class="graphic graphic_figure graphicRef108371" href="/z/d/graphic/108371.html" rel="external">
          figure 1
         </a>
         ). B and T cells respond through production of immunoglobulin G (IgG) and immunoglobulin M (IgM) antibody and activation of CD4+ T cells. A linked IgG3-C4 response appears to be important [
         <a href="#rid27">
          27
         </a>
         ]. In susceptible persons, there is a cross-reactive immune response. This may be mediated by molecular mimicry that involves both humoral and cellular components of the adaptive immune system. This cross-reactive response results in the clinical features of rheumatic fever including transient arthritis, chorea, and carditis due to antibody binding and infiltration of T cells.
        </p>
        <p class="headingAnchor" id="H5">
         <span class="h2">
          Role of
          <i>
           Streptococcus pyogenes
          </i>
         </span>
         <span class="headingEndMark">
          —
         </span>
         Although evidence for the direct involvement of GAS in the affected tissues of patients with ARF is lacking, significant epidemiologic evidence indirectly implicates GAS in the initiation of disease:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Outbreaks of ARF closely follow epidemics of streptococcal pharyngitis or scarlet fever with associated pharyngitis [
         <a href="#rid28">
          28,29
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Adequate treatment of a documented streptococcal pharyngitis reduces the incidence of subsequent ARF by nearly 70 percent [
         <a href="#rid30">
          30,31
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Appropriate antimicrobial prophylaxis prevents the recurrence of disease in patients who have had ARF [
         <a href="#rid32">
          32-34
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Most patients with ARF have elevated antibody titers to antistreptococcal antigens (streptolysin O,
         <em>
          anti-deoxyribonuclease
         </em>
         B
         <em>
          ,
         </em>
         hyaluronidase, streptokinase), whether or not they recall an antecedent sore throat [
         <a href="#rid35">
          35
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H1179395389">
         <span class="h2">
          Bacterial strain specificity
         </span>
         <span class="headingEndMark">
          —
         </span>
         Bacterial genetic factors may be an important determinant of the site of GAS infection. There are five chromosome patterns of
         <em>
          emm
         </em>
         genes, labeled A to E, that code for M and M-like cell surface virulence proteins. GAS fall into three classes based upon differences in the C repeat regions of the M protein [
         <a href="#rid36">
          36
         </a>
         ]. Pharyngeal strains typically have patterns A to C, impetigo strains show pattern D, and "generalist" strains (both pharyngeal and impetigo) are pattern E [
         <a href="#rid37">
          37,38
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/3167.html" rel="external">
          "Group A streptococcus: Virulence factors and pathogenic mechanisms", section on 'M and M-like proteins'
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/3167.html" rel="external">
          "Group A streptococcus: Virulence factors and pathogenic mechanisms", section on 'Ig-binding M-like proteins'
         </a>
         .)
        </p>
        <p>
         Certain
         <em>
          emm
         </em>
         types (types 3, 5, 6, 14, 18, 19, 24, and 29), all belonging to pattern A to C, were implicated in outbreaks of rheumatic fever in the United States in the 1960s and have been termed "rheumatogenic" strains of GAS [
         <a href="#rid17">
          17,32,39,40
         </a>
         ]. The decrease in the incidence of ARF in the US from the 1960s to the present correlated with the replacement of rheumatogenic types by nonrheumatogenic types. However, the prevalence of rheumatogenic strains decreased two- to fivefold, whereas the reduction in the incidence of ARF over the same period was ≥20-fold [
         <a href="#rid41">
          41
         </a>
         ]. Thus, a shift in the prevalence of so-called rheumatogenic
         <em>
          emm
         </em>
         types does not appear to fully explain the decrease in ARF.
        </p>
        <p>
         Other data, particularly from outside the US, suggest that there are no specific rheumatogenic strains [
         <a href="#rid42">
          42,43
         </a>
         ]. A systematic review of cases of ARF from around the world found 73 different
         <em>
          emm
         </em>
         types distributed across the GAS phylogeny associated with ARF, and only 12 percent of cases were associated with "rheumatogenic" strains [
         <a href="#rid43">
          43
         </a>
         ]. These data led the authors to challenge the concept of rheumatogenicity. As an example, a study in Hawaii observed that 8 of 63 patients with ARF had GAS isolated on throat swab at presentation (
         <em>
          emm
         </em>
         types 65/69, 71, 92, 93, 98, 103, and 122); none of these
         <em>
          emm
         </em>
         types are classically associated with ARF, and all belong to
         <em>
          emm
         </em>
         pattern D or E [
         <a href="#rid44">
          44
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H6">
         <span class="h2">
          The role of pharyngeal and skin infection
         </span>
         <span class="headingEndMark">
          —
         </span>
         Streptococcal pharyngitis is the only streptococcal infection that is clearly associated with ARF. The role of streptococcal skin infection (impetigo, pyoderma) in ARF remains unclear. GAS impetigo has not been proven to directly lead to ARF, but epidemiologic evidence in certain populations suggests some sort of role along the causal pathway [
         <a href="#rid42">
          42
         </a>
         ].
        </p>
        <p>
         Viral pharyngitis and pharyngitis caused by other bacteria do not result in ARF. A few theories have tried to explain why ARF is only associated with streptococcal pharyngitis, but the exact explanation remains obscure. The pharyngeal site of infection, with its large repository of lymphoid tissue, may be important in the initiation of the abnormal host response to those antigens cross-reactive with target organs.
        </p>
        <p>
         There are documented outbreaks of impetigo that caused acute glomerulonephritis (AGN) but almost never caused ARF [
         <a href="#rid45">
          45,46
         </a>
         ]. A study of patients in Trinidad with ARF or AGN diagnosed during an outbreak of scabies and secondary impetigo found that the streptococcal strains colonizing the skin in patients with impetigo were different from those associated with ARF [
         <a href="#rid46">
          46
         </a>
         ]. The presence of impetigo was associated with AGN but did not influence the incidence of ARF. Impetigo strains are able to colonize the pharynx but may not elicit as strong an immunologic response to the M protein moiety as pharyngeal strains [
         <a href="#rid47">
          47,48
         </a>
         ].
        </p>
        <p>
         Nevertheless, epidemiologic data and clinical experience in high-risk populations have challenged the theory that GAS skin infection does not play a role in the causal pathway of ARF. Aboriginal Australian and Pacific Island populations have very high rates of ARF, but pharyngeal carriage of GAS and symptomatic GAS tonsillopharyngitis are uncommon [
         <a href="#rid42">
          42,49-55
         </a>
         ]. A case-control study of ARF in New Zealand observed that ARF risk was increased after both self-reported sore throat (odds ratio 2.3) and skin infection (odds ratio 2.5) [
         <a href="#rid16">
          16
         </a>
         ]. A retrospective study of nearly two million throat and skin swabs in New Zealand found that ARF risk among Māori and Pacific Peoples increased following GAS detection in both throat and skin swabs (relative risk of 4.8 and 5.1 following a GAS-positive throat swab or skin swab, respectively) [
         <a href="#rid56">
          56
         </a>
         ]. Two main hypotheses have been suggested to explain the link between GAS skin infection and ARF. One hypothesis is that there is a direct initiation of ARF after skin infection, and a second is that repeated episodes of GAS pyoderma may prime the immune system before an episode of GAS pharyngitis directly triggers ARF [
         <a href="#rid49">
          49
         </a>
         ]. However, these hypotheses are unproven and require further exploration for confirmation.
        </p>
        <p class="headingAnchor" id="H7">
         <span class="h2">
          Molecular mimicry
         </span>
         <span class="headingEndMark">
          —
         </span>
         Molecular mimicry implies structural similarity between some infectious or other exogenous agent and human proteins, such that antibodies and T cells activated in response to the exogenous agent react with the human protein. In ARF, antibodies directed against GAS antigens cross-react with host antigens [
         <a href="#rid57">
          57-62
         </a>
         ]. In addition, human heart-intralesional T cell clones react with meromyosin, myosin, and valve-derived proteins, leading to an immunologic response to cardiac tissue and production of inflammatory cytokines [
         <a href="#rid63">
          63
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H8">
         <span class="h3">
          Carditis
         </span>
         <span class="headingEndMark">
          —
         </span>
         The alpha-helical protein structures found in M protein and N-acetyl-beta-D-glucosamine (NABG; the immunodominant carbohydrate antigen of GAS) share epitopes with myosin, and antibody crossreactivity has been demonstrated in humans [
         <a href="#rid58">
          58-61
         </a>
         ]. In a rodent model, immunization with recombinant streptococcal M protein type 6 leads to development of both valvulitis and focal cardiac myositis [
         <a href="#rid25">
          25
         </a>
         ]. There do not appear to be cross-reactive responses against the N-terminal and A-repeat regions of the M protein. These regions are responsible for type-specific immunity and have been used in GAS vaccine studies with no evidence of cross-reactivity in animal or human subjects [
         <a href="#rid64">
          64
         </a>
         ].
        </p>
        <p>
         In one study, monoclonal antibodies generated from tonsillar or peripheral blood lymphocytes of patients infected with GAS cross-reacted with myosin and certain other proteins [
         <a href="#rid60">
          60
         </a>
         ]. In addition, antimyosin antibodies purified from patients with ARF cross-reacted with GAS and M protein. Similar antibodies were present in much lower concentrations in some normal subjects.
        </p>
        <p>
         In a later report, a monoclonal antibody directed against myosin and NABG was isolated from a patient with rheumatic carditis [
         <a href="#rid61">
          61
         </a>
         ]. The antibody was cytotoxic for human endothelial cell lines and reacted with human valvular endothelium. This reactivity was inhibited by myosin&gt;laminin&gt;NABG. The reactivity with the extracellular matrix protein laminin may explain the reactivity against the valve surface.
        </p>
        <p>
         Autoreactive T cells appear to play an important role in the formation of Aschoff nodules in cardiac valves. Vascular cell adhesion molecule 1 (VACM1) appears to be the link between humoral and cellular immunity at the valve surface [
         <a href="#rid65">
          65
         </a>
         ]. VCAM1 is upregulated on the surface of the valve endothelium following binding of cross-reactive antibodies. This leads to adherence of T cells (predominantly CD4+) to the endothelium, with subsequent infiltration of these cells into the valve resulting in the formation of granulomatous lesions (Aschoff bodies) underneath the endocardium [
         <a href="#rid65">
          65
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H9">
         <span class="h3">
          Chorea
         </span>
         <span class="headingEndMark">
          —
         </span>
         Molecular mimicry may also be involved in the development of Sydenham chorea in patients with ARF. In an animal model, monoclonal antibodies that caused chorea bound to both NABG and mammalian lysoganglioside [
         <a href="#rid62">
          62
         </a>
         ]. Exposure of cultured human neuronal cells to either monoclonal antibodies or serum from patients with chorea led to induction of calcium/calmodulin protein kinase. Exposure to serum from patients following streptococcal infection that was not complicated by chorea did not have this effect on neuronal cells. (See
         <a class="medical medical_review" href="/z/d/html/6228.html" rel="external">
          "Sydenham chorea"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H10">
         <span class="h2">
          Genetic susceptibility
         </span>
         <span class="headingEndMark">
          —
         </span>
         The concept that ARF might result from a host genetic predisposition has intrigued investigators for more than 100 years [
         <a href="#rid66">
          66-69
         </a>
         ]. ARF appears to be a highly heritable disease [
         <a href="#rid70">
          70
         </a>
         ], and susceptibility to ARF is most likely polygenic.
        </p>
        <p>
         A meta-analysis of twin studies found that the pooled proband-wise concordance risk was 44 percent in monozygotic twins and 12 percent in dizygotic twins. The association between zygosity and concordance was strong, with an odds ratio of 6.4 (95% CI 3.4-12.1) [
         <a href="#rid71">
          71
         </a>
         ].
        </p>
        <p>
         Polymorphisms in several genes encoding immune proteins are associated with ARF susceptibility. Large-scale, genome-wide association studies (GWAS) of rheumatic heart disease in multiple populations in over 20 countries in Africa, the Pacific, South Asia, Europe, and northern Australia are underway or completed [
         <a href="#rid72">
          72-74
         </a>
         ]. The first GWAS, conducted among 2582 persons in seven countries in Oceania, observed a susceptibility signal in the immunoglobulin heavy chain locus suggesting a central role of humoral immunity in the pathogenesis of rheumatic fever [
         <a href="#rid75">
          75
         </a>
         ]. The second GWAS, conducted among 1263 persons in indigenous communities of Australia, found variation at the class II region of the human leukocyte antigen [
         <a href="#rid76">
          76
         </a>
         ], consistent with previous smaller studies [
         <a href="#rid77">
          77-79
         </a>
         ]. The third study, of 2622 persons in South Asian or Europe, identified a susceptibility signal in the class III region of the human leukocyte antigen [
         <a href="#rid80">
          80
         </a>
         ]. The fourth study, of 4809 participants from eight countries in Africa, identified a single risk locus among Black African persons at 11q24.1, an intergenic region containing long noncoding transcripts [
         <a href="#rid81">
          81
         </a>
         ]. A meta-analysis of Black and multiracial persons identified several suggestive susceptibility signals including the same immunoglobulin heavy-chain locus identified in the Oceania GWAS [
         <a href="#rid81">
          81
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H10703183">
         <span class="h1">
          SUMMARY
         </span>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Definition
         </strong>
         – Acute rheumatic fever (ARF) is a delayed, nonsuppurative sequela of infection with group A
         <em>
          Streptococcus
         </em>
         (GAS). (See
         <a class="local">
          'Introduction'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Epidemiology
         </strong>
         – Most cases of ARF occur in children 5 to 15 years of age. ARF is more common in low-resource than high-resource countries. (See
         <a class="local">
          'Epidemiology'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Pathogenesis
         </strong>
         – The pathogenic mechanisms that lead to the development of ARF remain incompletely understood. Streptococcal pharyngeal infection is required, and activation of autoreactive B and T cells by GAS antigens is thought to play an important role in the initiation of the tissue injury. Genetic susceptibility may also be a factor. (See
         <a class="local">
          'Pathogenesis'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H710245970">
         <span class="h1">
          ACKNOWLEDGMENT
         </span>
         <span class="headingEndMark">
          —
         </span>
         The editorial staff at UpToDate acknowledge John B Zabriskie, MD, who contributed to earlier versions of this topic review.
        </p>
       </div>
       <div class="headingAnchor" id="references">
        <ol id="reference">
         <li>
          <a class="nounderline abstract_t">
           RAMMELKAMP CH Jr, STOLZER BL. The latent period before the onset of acute rheumatic fever. Yale J Biol Med 1961; 34:386.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Watkins DA, Johnson CO, Colquhoun SM, et al. Global, Regional, and National Burden of Rheumatic Heart Disease, 1990-2015. N Engl J Med 2017; 377:713.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Lawrence JG, Carapetis JR, Griffiths K, et al. Acute rheumatic fever and rheumatic heart disease: incidence and progression in the Northern Territory of Australia, 1997 to 2010. Circulation 2013; 128:492.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Parnaby MG, Carapetis JR. Rheumatic fever in indigenous Australian children. J Paediatr Child Health 2010; 46:527.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Seckeler MD, Barton LL, Brownstein R. The persistent challenge of rheumatic fever in the Northern Mariana Islands. Int J Infect Dis 2010; 14:e226.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Carapetis JR, Steer AC, Mulholland EK, Weber M. The global burden of group A streptococcal diseases. Lancet Infect Dis 2005; 5:685.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Carapetis JR. Rheumatic heart disease in developing countries. N Engl J Med 2007; 357:439.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Zühlke LJ, Steer AC. Estimates of the global burden of rheumatic heart disease. Glob Heart 2013; 8:189.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           GBD 2013 Mortality and Causes of Death Collaborators. Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet 2015; 385:117.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Noonan S, Zurynski YA, Currie BJ, et al. A national prospective surveillance study of acute rheumatic fever in Australian children. Pediatr Infect Dis J 2013; 32:e26.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Tibazarwa KB, Volmink JA, Mayosi BM. Incidence of acute rheumatic fever in the world: a systematic review of population-based studies. Heart 2008; 94:1534.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Miyake CY, Gauvreau K, Tani LY, et al. Characteristics of children discharged from hospitals in the United States in 2000 with the diagnosis of acute rheumatic fever. Pediatrics 2007; 120:503.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Gordis L. The virtual disappearance of rheumatic fever in the United States: lessons in the rise and fall of disease. T. Duckett Jones memorial lecture. Circulation 1985; 72:1155.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Oliver J, Osowicki J, Cordell B, et al. Incidence of acute rheumatic fever and rheumatic heart disease in Melbourne, Australia from 1937 to 2013. J Paediatr Child Health 2020; 56:1408.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Jaine R, Baker M, Venugopal K. Acute rheumatic fever associated with household crowding in a developed country. Pediatr Infect Dis J 2011; 30:315.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Baker MG, Gurney J, Moreland NJ, et al. Risk factors for acute rheumatic fever: A case-control study. Lancet Reg Health West Pac 2022; 26:100508.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Stollerman GH. Rheumatic fever. Lancet 1997; 349:935.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Veasy LG, Wiedmeier SE, Orsmond GS, et al. Resurgence of acute rheumatic fever in the intermountain area of the United States. N Engl J Med 1987; 316:421.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Hoffman TM, Rhodes LA, Pyles LA, et al. Childhood acute rheumatic fever: a comparison of recent resurgence areas to cases in West Virginia. W V Med J 1997; 93:260.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Veasy LG, Tani LY, Hill HR. Persistence of acute rheumatic fever in the intermountain area of the United States. J Pediatr 1994; 124:9.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Westlake RM, Graham TP, Edwards KM. An outbreak of acute rheumatic fever in Tennessee. Pediatr Infect Dis J 1990; 9:97.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Hosier DM, Craenen JM, Teske DW, Wheller JJ. Resurgence of acute rheumatic fever. Am J Dis Child 1987; 141:730.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Bisno AL. The resurgence of acute rheumatic fever in the United States. Annu Rev Med 1990; 41:319.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Siegel AC, Johnson EE, Stollerman GH. Controlled studies of streptococcal pharyngitis in a pediatric population, 1: factors related to the attack rate of rheumatic fever. N Engl J Med 1961; 265:559.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Quinn A, Kosanke S, Fischetti VA, et al. Induction of autoimmune valvular heart disease by recombinant streptococcal m protein. Infect Immun 2001; 69:4072.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Brimberg L, Benhar I, Mascaro-Blanco A, et al. Behavioral, pharmacological, and immunological abnormalities after streptococcal exposure: a novel rat model of Sydenham chorea and related neuropsychiatric disorders. Neuropsychopharmacology 2012; 37:2076.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Chung AW, Ho TK, Hanson-Manful P, et al. Systems immunology reveals a linked IgG3-C4 response in patients with acute rheumatic fever. Immunol Cell Biol 2020; 98:12.
          </a>
         </li>
         <li class="breakAll">
          Whitnack E, Bisno L. Rheumatic fever and other immunologically-mediated cardiac diseases. In: Clinical immunology, Parker C (Ed), WB Saunders, Philadelphia 1980. Vol 2, p.894.
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kaplan EL, Bisno AL. Antecedent streptococcal infection in acute rheumatic fever. Clin Infect Dis 2006; 43:690.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           DENNY FW, WANNAMAKER LW, BRINK WR, et al. Prevention of rheumatic fever; treatment of the preceding streptococcic infection. J Am Med Assoc 1950; 143:151.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Robertson KA, Volmink JA, Mayosi BM. Antibiotics for the primary prevention of acute rheumatic fever: a meta-analysis. BMC Cardiovasc Disord 2005; 5:11.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Markowitz M, Gerber MA. Rheumatic fever: recent outbreaks of an old disease. Conn Med 1987; 51:229.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Shulman ST, Gerber MA, Tanz RR, Markowitz M. Streptococcal pharyngitis: the case for penicillin therapy. Pediatr Infect Dis J 1994; 13:1.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Manyemba J, Mayosi BM. Penicillin for secondary prevention of rheumatic fever. Cochrane Database Syst Rev 2002; :CD002227.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           STOLLERMAN GH, LEWIS AJ, SCHULTZ I, TARANTA A. Relationship of immune response to group A streptococci to the course of acute, chronic and recurrent rheumatic fever. Am J Med 1956; 20:163.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Bessen D, Jones KF, Fischetti VA. Evidence for two distinct classes of streptococcal M protein and their relationship to rheumatic fever. J Exp Med 1989; 169:269.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Bessen DE, Sotir CM, Readdy TL, Hollingshead SK. Genetic correlates of throat and skin isolates of group A streptococci. J Infect Dis 1996; 173:896.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           McMillan DJ, Drèze PA, Vu T, et al. Updated model of group A Streptococcus M proteins based on a comprehensive worldwide study. Clin Microbiol Infect 2013; 19:E222.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Shulman ST, Stollerman G, Beall B, et al. Temporal changes in streptococcal M protein types and the near-disappearance of acute rheumatic fever in the United States. Clin Infect Dis 2006; 42:441.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Johnson DR, Stevens DL, Kaplan EL. Epidemiologic analysis of group A streptococcal serotypes associated with severe systemic infections, rheumatic fever, or uncomplicated pharyngitis. J Infect Dis 1992; 166:374.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Lee GM, Wessels MR. Changing epidemiology of acute rheumatic fever in the United States. Clin Infect Dis 2006; 42:448.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Parks T, Smeesters PR, Steer AC. Streptococcal skin infection and rheumatic heart disease. Curr Opin Infect Dis 2012; 25:145.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           de Crombrugghe G, Baroux N, Botteaux A, et al. The Limitations of the Rheumatogenic Concept for Group A Streptococcus: Systematic Review and Genetic Analysis. Clin Infect Dis 2020; 70:1453.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Erdem G, Mizumoto C, Esaki D, et al. Group A streptococcal isolates temporally associated with acute rheumatic fever in Hawaii: differences from the continental United States. Clin Infect Dis 2007; 45:e20.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Anthony BF, Kaplan EL, Wannamaker LW, et al. Attack rates of acute nephritis after type 49 streptococcal infection of the skin and of the respiratory tract. J Clin Invest 1969; 48:1697.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Potter EV, Svartman M, Mohammed I, et al. Tropical acute rheumatic fever and associated streptococcal infections compared with concurrent acute glomerulonephritis. J Pediatr 1978; 92:325.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kaplan EL, Anthony BF, Chapman SS, et al. The influence of the site of infection on the immune response to group A streptococci. J Clin Invest 1970; 49:1405.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Bisno AL, Nelson KE. Type-specific opsonic antibodies in streptococcal pyoderma. Infect Immun 1974; 10:1356.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           McDonald M, Currie BJ, Carapetis JR. Acute rheumatic fever: a chink in the chain that links the heart to the throat? Lancet Infect Dis 2004; 4:240.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           McDonald MI, Towers RJ, Andrews RM, et al. Low rates of streptococcal pharyngitis and high rates of pyoderma in Australian aboriginal communities where acute rheumatic fever is hyperendemic. Clin Infect Dis 2006; 43:683.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Steer AC, Jenney AW, Kado J, et al. High burden of impetigo and scabies in a tropical country. PLoS Negl Trop Dis 2009; 3:e467.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Steer AC, Kado J, Jenney AW, et al. Acute rheumatic fever and rheumatic heart disease in Fiji: prospective surveillance, 2005-2007. Med J Aust 2009; 190:133.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Steer AC, Kado J, Wilson N, et al. High prevalence of rheumatic heart disease by clinical and echocardiographic screening among children in Fiji. J Heart Valve Dis 2009; 18:327.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Steer AC, Jenney AW, Kado J, et al. Prospective surveillance of streptococcal sore throat in a tropical country. Pediatr Infect Dis J 2009; 28:477.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Steer AC, Adams J, Carlin J, et al. Rheumatic heart disease in school children in Samoa. Arch Dis Child 1999; 81:372.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Oliver J, Bennett J, Thomas S, et al. Preceding group A streptococcus skin and throat infections are individually associated with acute rheumatic fever: evidence from New Zealand. BMJ Glob Health 2021; 6.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           van de Rijn I, Zabriskie JB, McCarty M. Group A streptococcal antigens cross-reactive with myocardium. Purification of heart-reactive antibody and isolation and characterization of the streptococcal antigen. J Exp Med 1977; 146:579.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Dale JB, Beachey EH. Epitopes of streptococcal M proteins shared with cardiac myosin. J Exp Med 1985; 162:583.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Cunningham MW, McCormack JM, Fenderson PG, et al. Human and murine antibodies cross-reactive with streptococcal M protein and myosin recognize the sequence GLN-LYS-SER-LYS-GLN in M protein. J Immunol 1989; 143:2677.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Cunningham MW, McCormack JM, Talaber LR, et al. Human monoclonal antibodies reactive with antigens of the group A Streptococcus and human heart. J Immunol 1988; 141:2760.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Galvin JE, Hemric ME, Ward K, Cunningham MW. Cytotoxic mAb from rheumatic carditis recognizes heart valves and laminin. J Clin Invest 2000; 106:217.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kirvan CA, Swedo SE, Heuser JS, Cunningham MW. Mimicry and autoantibody-mediated neuronal cell signaling in Sydenham chorea. Nat Med 2003; 9:914.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Faé KC, da Silva DD, Oshiro SE, et al. Mimicry in recognition of cardiac myosin peptides by heart-intralesional T cell clones from rheumatic heart disease. J Immunol 2006; 176:5662.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           McNeil SA, Halperin SA, Langley JM, et al. Safety and immunogenicity of 26-valent group a streptococcus vaccine in healthy adult volunteers. Clin Infect Dis 2005; 41:1114.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Roberts S, Kosanke S, Terrence Dunn S, et al. Pathogenic mechanisms in rheumatic carditis: focus on valvular endothelium. J Infect Dis 2001; 183:507.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Cheadle WB. Harvean lectures on the various manifestations of the rheumatic state as exemplified in childhood and early life. Lancet 1889; 1:821.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Wilson MG, Schweitzr MD, Lubschez R. The familial epidemiology of rheumatic fever. J Pediatr 1943; 44:468.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Taranta A, Torosdag S, Metrakos JD, et al. Rheumatic fever in monozygotic and dizygotic twins. Circulation 1959; 20:778.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           GLYNN LE, HOLBOROW EJ. Relation between blood groups, secretor status and susceptibility to rheumatic fever. Arthritis Rheum 1961; 4:203.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Bryant PA, Robins-Browne R, Carapetis JR, Curtis N. Some of the people, some of the time: susceptibility to acute rheumatic fever. Circulation 2009; 119:742.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Engel ME, Stander R, Vogel J, et al. Genetic susceptibility to acute rheumatic fever: a systematic review and meta-analysis of twin studies. PLoS One 2011; 6:e25326.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Azevedo PM, Merriman TR, Topless RK, et al. Association study involving polymorphisms in IL-6, IL-1RA, and CTLA4 genes and rheumatic heart disease in New Zealand population of Māori and Pacific ancestry. Cytokine 2016; 85:201.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Herath VC, Carapetis J. Rheumatic Fever: What is New? Current Pediatric Reports 2015; 3:211.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Machipisa T, Chishala C, Shaboodien G, et al. Rationale, Design, and the Baseline Characteristics of the RHDGen (The Genetics of Rheumatic Heart Disease) Network Study†. Circ Genom Precis Med 2023; 16:e003641.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Parks T, Mirabel MM, Kado J, et al. Association between a common immunoglobulin heavy chain allele and rheumatic heart disease risk in Oceania. Nat Commun 2017; 8:14946.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Gray LA, D'Antoine HA, Tong SYC, et al. Genome-Wide Analysis of Genetic Risk Factors for Rheumatic Heart Disease in Aboriginal Australians Provides Support for Pathogenic Molecular Mimicry. J Infect Dis 2017; 216:1460.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Ayoub EM, Barrett DJ, Maclaren NK, Krischer JP. Association of class II human histocompatibility leukocyte antigens with rheumatic fever. J Clin Invest 1986; 77:2019.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Maharaj B, Hammond MG, Appadoo B, et al. HLA-A, B, DR, and DQ antigens in black patients with severe chronic rheumatic heart disease. Circulation 1987; 76:259.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Guilherme L, Weidebach W, Kiss MH, et al. Association of human leukocyte class II antigens with rheumatic fever or rheumatic heart disease in a Brazilian population. Circulation 1991; 83:1995.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Auckland K, Mittal B, Cairns BJ, et al. The Human Leukocyte Antigen Locus and Rheumatic Heart Disease Susceptibility in South Asians and Europeans. Sci Rep 2020; 10:9004.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Machipisa T, Chong M, Muhamed B, et al. Association of Novel Locus With Rheumatic Heart Disease in Black African Individuals: Findings From the RHDGen Study. JAMA Cardiol 2021; 6:1000.
          </a>
         </li>
        </ol>
       </div>
       <div id="topicVersionRevision">
        Topic 3151 Version 17.0
       </div>
      </div>
      <div class="row">
       <div class="col-12">
        <h4 style="text-align: center;padding: 20px;color: cadetblue;">
         References
        </h4>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/14490142" id="rid0" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          1 : The latent period before the onset of acute rheumatic fever.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/28834488" id="rid1" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          2 : Global, Regional, and National Burden of Rheumatic Heart Disease, 1990-2015.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23794730" id="rid2" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          3 : Acute rheumatic fever and rheumatic heart disease: incidence and progression in the Northern Territory of Australia, 1997 to 2010.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/20854325" id="rid3" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          4 : Rheumatic fever in indigenous Australian children.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19648043" id="rid4" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          5 : The persistent challenge of rheumatic fever in the Northern Mariana Islands.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16253886" id="rid5" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          6 : The global burden of group A streptococcal diseases.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17671252" id="rid6" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          7 : Rheumatic heart disease in developing countries.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25690495" id="rid7" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          8 : Estimates of the global burden of rheumatic heart disease.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25530442" id="rid8" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          9 : Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22926211" id="rid9" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          10 : A national prospective surveillance study of acute rheumatic fever in Australian children.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18669552" id="rid10" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          11 : Incidence of acute rheumatic fever in the world: a systematic review of population-based studies.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17766522" id="rid11" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          12 : Characteristics of children discharged from hospitals in the United States in 2000 with the diagnosis of acute rheumatic fever.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/4064266" id="rid12" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          13 : The virtual disappearance of rheumatic fever in the United States: lessons in the rise and fall of disease. T. Duckett Jones memorial lecture.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/32640123" id="rid13" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          14 : Incidence of acute rheumatic fever and rheumatic heart disease in Melbourne, Australia from 1937 to 2013.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/20948456" id="rid14" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          15 : Acute rheumatic fever associated with household crowding in a developed country.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/36213134" id="rid15" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          16 : Risk factors for acute rheumatic fever: A case-control study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9093263" id="rid16" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          17 : Rheumatic fever.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/3807984" id="rid17" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          18 : Resurgence of acute rheumatic fever in the intermountain area of the United States.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9383340" id="rid18" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          19 : Childhood acute rheumatic fever: a comparison of recent resurgence areas to cases in West Virginia.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/7802743" id="rid19" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          20 : Persistence of acute rheumatic fever in the intermountain area of the United States.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/2179847" id="rid20" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          21 : An outbreak of acute rheumatic fever in Tennessee.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/3591761" id="rid21" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          22 : Resurgence of acute rheumatic fever.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/2184733" id="rid22" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          23 : The resurgence of acute rheumatic fever in the United States.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/" id="rid23" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          24 : Controlled studies of streptococcal pharyngitis in a pediatric population, 1: factors related to the attack rate of rheumatic fever
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11349078" id="rid24" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          25 : Induction of autoimmune valvular heart disease by recombinant streptococcal m protein.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22534626" id="rid25" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          26 : Behavioral, pharmacological, and immunological abnormalities after streptococcal exposure: a novel rat model of Sydenham chorea and related neuropsychiatric disorders.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/31742781" id="rid26" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          27 : Systems immunology reveals a linked IgG3-C4 response in patients with acute rheumatic fever.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/31742781" id="rid27" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          28 : Systems immunology reveals a linked IgG3-C4 response in patients with acute rheumatic fever.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16912940" id="rid28" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          29 : Antecedent streptococcal infection in acute rheumatic fever.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15415234" id="rid29" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          30 : Prevention of rheumatic fever; treatment of the preceding streptococcic infection.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15927077" id="rid30" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          31 : Antibiotics for the primary prevention of acute rheumatic fever: a meta-analysis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/3581830" id="rid31" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          32 : Rheumatic fever: recent outbreaks of an old disease.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8170725" id="rid32" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          33 : Streptococcal pharyngitis: the case for penicillin therapy.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12137650" id="rid33" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          34 : Penicillin for secondary prevention of rheumatic fever.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/13282935" id="rid34" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          35 : Relationship of immune response to group A streptococci to the course of acute, chronic and recurrent rheumatic fever.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/2642529" id="rid35" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          36 : Evidence for two distinct classes of streptococcal M protein and their relationship to rheumatic fever.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8603968" id="rid36" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          37 : Genetic correlates of throat and skin isolates of group A streptococci.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23464795" id="rid37" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          38 : Updated model of group A Streptococcus M proteins based on a comprehensive worldwide study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16421785" id="rid38" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          39 : Temporal changes in streptococcal M protein types and the near-disappearance of acute rheumatic fever in the United States.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/1634809" id="rid39" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          40 : Epidemiologic analysis of group A streptococcal serotypes associated with severe systemic infections, rheumatic fever, or uncomplicated pharyngitis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16421786" id="rid40" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          41 : Changing epidemiology of acute rheumatic fever in the United States.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22327467" id="rid41" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          42 : Streptococcal skin infection and rheumatic heart disease.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/31334754" id="rid42" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          43 : The Limitations of the Rheumatogenic Concept for Group A Streptococcus: Systematic Review and Genetic Analysis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17599299" id="rid43" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          44 : Group A streptococcal isolates temporally associated with acute rheumatic fever in Hawaii: differences from the continental United States.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/5822578" id="rid44" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          45 : Attack rates of acute nephritis after type 49 streptococcal infection of the skin and of the respiratory tract.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/340631" id="rid45" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          46 : Tropical acute rheumatic fever and associated streptococcal infections compared with concurrent acute glomerulonephritis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/5432372" id="rid46" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          47 : The influence of the site of infection on the immune response to group A streptococci.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/4435959" id="rid47" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          48 : Type-specific opsonic antibodies in streptococcal pyoderma.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15050943" id="rid48" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          49 : Acute rheumatic fever: a chink in the chain that links the heart to the throat?
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16912939" id="rid49" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          50 : Low rates of streptococcal pharyngitis and high rates of pyoderma in Australian aboriginal communities where acute rheumatic fever is hyperendemic.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19547749" id="rid50" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          51 : High burden of impetigo and scabies in a tropical country.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19203310" id="rid51" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          52 : Acute rheumatic fever and rheumatic heart disease in Fiji: prospective surveillance, 2005-2007.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19557993" id="rid52" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          53 : High prevalence of rheumatic heart disease by clinical and echocardiographic screening among children in Fiji.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19483515" id="rid53" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          54 : Prospective surveillance of streptococcal sore throat in a tropical country.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10577365" id="rid54" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          55 : Rheumatic heart disease in school children in Samoa.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/34887304" id="rid55" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          56 : Preceding group A streptococcus skin and throat infections are individually associated with acute rheumatic fever: evidence from New Zealand.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/327018" id="rid56" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          57 : Group A streptococcal antigens cross-reactive with myocardium. Purification of heart-reactive antibody and isolation and characterization of the streptococcal antigen.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/2410530" id="rid57" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          58 : Epitopes of streptococcal M proteins shared with cardiac myosin.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/2677144" id="rid58" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          59 : Human and murine antibodies cross-reactive with streptococcal M protein and myosin recognize the sequence GLN-LYS-SER-LYS-GLN in M protein.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/3049816" id="rid59" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          60 : Human monoclonal antibodies reactive with antigens of the group A Streptococcus and human heart.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10903337" id="rid60" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          61 : Cytotoxic mAb from rheumatic carditis recognizes heart valves and laminin.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12819778" id="rid61" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          62 : Mimicry and autoantibody-mediated neuronal cell signaling in Sydenham chorea.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16622036" id="rid62" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          63 : Mimicry in recognition of cardiac myosin peptides by heart-intralesional T cell clones from rheumatic heart disease.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16163629" id="rid63" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          64 : Safety and immunogenicity of 26-valent group a streptococcus vaccine in healthy adult volunteers.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11133385" id="rid64" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          65 : Pathogenic mechanisms in rheumatic carditis: focus on valvular endothelium.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/" id="rid65" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          66 : Harvean lectures on the various manifestations of the rheumatic state as exemplified in childhood and early life
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/" id="rid66" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          67 : The familial epidemiology of rheumatic fever
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/" id="rid67" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          68 : Rheumatic fever in monozygotic and dizygotic twins
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/13706123" id="rid68" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          69 : Relation between blood groups, secretor status and susceptibility to rheumatic fever.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19204317" id="rid69" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          70 : Some of the people, some of the time: susceptibility to acute rheumatic fever.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21980428" id="rid70" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          71 : Genetic susceptibility to acute rheumatic fever: a systematic review and meta-analysis of twin studies.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/27400406" id="rid71" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          72 : Association study involving polymorphisms in IL-6, IL-1RA, and CTLA4 genes and rheumatic heart disease in New Zealand population of Māori and Pacific ancestry.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/" id="rid72" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          73 : Rheumatic Fever: What is New?
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/36548480" id="rid73" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          74 : Rationale, Design, and the Baseline Characteristics of the RHDGen (The Genetics of Rheumatic Heart Disease) Network Study†.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/28492228" id="rid74" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          75 : Association between a common immunoglobulin heavy chain allele and rheumatic heart disease risk in Oceania.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/29029143" id="rid75" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          76 : Genome-Wide Analysis of Genetic Risk Factors for Rheumatic Heart Disease in Aboriginal Australians Provides Support for Pathogenic Molecular Mimicry.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/3486889" id="rid76" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          77 : Association of class II human histocompatibility leukocyte antigens with rheumatic fever.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/3475188" id="rid77" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          78 : HLA-A, B, DR, and DQ antigens in black patients with severe chronic rheumatic heart disease.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/2040052" id="rid78" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          79 : Association of human leukocyte class II antigens with rheumatic fever or rheumatic heart disease in a Brazilian population.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/32488134" id="rid79" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          80 : The Human Leukocyte Antigen Locus and Rheumatic Heart Disease Susceptibility in South Asians and Europeans.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/34106200" id="rid80" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          81 : Association of Novel Locus With Rheumatic Heart Disease in Black African Individuals: Findings From the RHDGen Study.
         </p>
        </a>
       </div>
      </div>
     </div>
    </div>
   </section>
  </section>
  <!-- End Main Menu Area -->
  <!-- Start Search Popup Area -->
  <!-- End Footer Area -->
  <!-- Back to top -->
  <a class="scrolltop" href="#top">
   <i class="icofont-hand-drawn-up">
   </i>
  </a>
  <!-- End Back to top -->
  <!-- jQuery Min JS -->
  <!-- Prpper JS -->
  <!-- Bootstrap Min JS -->
  <!-- Classy Nav Min Js -->
  <!-- Owl Carousel Min Js -->
  <!-- Magnific Popup JS -->
  <!-- CounterUp JS -->
  <!-- Waypoints JS -->
  <!-- Form Validator Min JS -->
  <!-- Contact Form Min JS -->
  <!-- Main JS -->
  <!-- Global site tag (gtag.js) - Google Analytics -->
 </body>
</html>
